James Weaver, MS

Janssen Pharmaceuticals, Inc.
University of Oxford
Titusville, New Jersey, United States

Janssen R&D (Employment, Ownership Interest includes stock, stock options, patent or other intellectual property)

Presentation(s):

• Evaluating the Comparative Effectiveness and Safety of Repurposed Drugs for COVID-19

  Friday, August 26, 2022
  6:00 PM – 6:15 PM CEST